Health Boards
Mon-26-04-2021, 00:29 AM
They might have to lower the dose a bit. Clearance is not so great if it increases risk. Always hard finding a balance.
|
Bimekizumab phase 3 studies in psoriasis
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Bimekizumab phase 3 studies in psoriasis - by Fred - Sat-24-04-2021, 11:31 AM
RE: Bimekizumab phase 3 studies in psoriasis - by Turnedlight - Sat-24-04-2021, 16:09 PM
RE: Bimekizumab phase 3 studies in psoriasis - by Bill - Mon-26-04-2021, 00:29 AM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
More studies needed on IL-30 in psoriasis patients | Fred | 0 | 2,201 |
Mon-03-05-2021, 21:31 PM Last Post: Fred |
|
|
Bimekizumab beat Cosentyx in psoriasis skin clearance head to head | Fred | 0 | 2,477 |
Fri-24-07-2020, 11:57 AM Last Post: Fred |
|
|
Usefulness and reliability of insurance databases in psoriasis studies | Fred | 1 | 2,948 |
Sun-17-05-2020, 21:27 PM Last Post: Caroline |
|
|
More unbiased studies needed to improve psoriasis diagnoses | Fred | 3 | 4,595 |
Sat-01-02-2020, 21:48 PM Last Post: Caroline |
|
|
Bimekizumab BE ABLE 2 Extension Study | Fred | 0 | 2,453 |
Sat-02-03-2019, 14:42 PM Last Post: Fred |
Users browsing this thread: 1 Guest(s)